The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Aggresomes, inclusion bodies and protein aggregation
Kopito, R. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01852-3 · Cited by 1,921
McCormack, A. L., Thiruchelvam, M., Manning-Bog, A. B., Thiffault, C., Langston, J. W., Cory-Slechta, D. A., & Di Monte, D. A. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0507 · Cited by 838
A highly reproducible rotenone model of Parkinson's disease
Cannon, J. R., Tapias, V., Na, H. M., Honick, A. S., Drolet, R. E., & Greenamyre, J. T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.016 · Cited by 795
Sherer, T. B., Kim, J.-H., Betarbet, R., & Greenamyre, J. T. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8072 · Cited by 708
The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice
Manning-Bog, A. B., McCormack, A. L., Li, J., Uversky, V. N., Fink, A. L., & Di Monte, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100560200 · Cited by 684
Thiruchelvam, M., Richfield, E. K., Baggs, R. B., Tank, A. W., & Cory-Slechta, D. A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09207.2000 · Cited by 471
The pathogenesis of cell death in Parkinson's disease
Jenner, P., & Olanow, C. W. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s24 · Cited by 446
Pesticide exposure and risk for Parkinson's disease
Ascherio, A., Chen, H., Weisskopf, M. G., O'Reilly, E., McCullough, M. L., Calle, E. E., Schwarzschild, M. A., & Thun, M. J. (2006) · Annals of Neurology · doi:10.1002/ana.20904 · Cited by 445
Betarbet, R., Canet-Aviles, R. M., Sherer, T. B., Mastroberardino, P. G., McLendon, C., Kim, J.-H., Lund, S., Na, H.-M., Taylor, G., Bence, N. F., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.003 · Cited by 342
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
Höglinger, G. U., Féger, J., Prigent, A., Michel, P. P., Parain, K., Champy, P., Ruberg, M., Oertel, W. H., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01533.x · Cited by 331
Thiruchelvam, M., Brockel, B. J., Richfield, E. K., Baggs, R. B., & Cory-Slechta, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02496-3 · Cited by 324
Parkinson's disease and pesticides: a toxicological perspective
HATCHER, J., PENNELL, K., & MILLER, G. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.03.007 · Cited by 319
Uversky, V. N. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0937-z · Cited by 312
Thiruchelvam, M., McCormack, A., Richfield, E. K., Baggs, R. B., Tank, A. W., Di Monte, D. A., & Cory‐Slechta, D. A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02781.x · Cited by 280
Carrier-mediated processes in blood–brain barrier penetration and neural uptake of paraquat
Shimizu, K., Ohtaki, K., Matsubara, K., Aoyama, K., Uezono, T., Saito, O., Suno, M., Ogawa, K., Hayase, N., Kimura, K., et al. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02577-x · Cited by 263
Inden, M., Kitamura, Y., Takeuchi, H., Yanagida, T., Takata, K., Kobayashi, Y., Taniguchi, T., Yoshimoto, K., Kaneko, M., Okuma, Y., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04440.x · Cited by 260
Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication
Ferraz, H. B., F. Bertolucci, P. H., Pereira, J. S., Lima, J. G. C., & F. Andrade, L. A. (1988) · Neurology · doi:10.1212/wnl.38.4.550 · Cited by 260
Ling, Z., Gayle, D. A., Ma, S. Y., Lipton, J. W., Tong, C. W., Hong, J., & Carvey, P. M. (2002) · Movement Disorders · doi:10.1002/mds.10078 · Cited by 241
Zhang, J., Fitsanakis, V. A., Gu, G., Jing, D., Ao, M., Amarnath, V., & Montine, T. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01525.x · Cited by 237
Peng, J., Mao, X. O., Stevenson, F. F., Hsu, M., & Andersen, J. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404596200 · Cited by 233
FLEMING, S. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.023 · Cited by 230
Developmental Exposure to the Pesticides Paraquat and Maneb and the Parkinson’s Disease Phenotype
Thiruchelvam, M., Richfield, E. K., Goodman, B. M., Baggs, R. B., & Cory-Slechta, D. A. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00092-x · Cited by 214
Overview of the Extranigral Aspects of Parkinson Disease
Lim, S.-Y., Fox, S. H., & Lang, A. E. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.561 · Cited by 207
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy
Höglinger, G. U., Lannuzel, A., Khondiker, M. E., Michel, P. P., Duyckaerts, C., Féger, J., Champy, P., Prigent, A., Medja, F., Lombes, A., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03493.x · Cited by 203
Rotenone induces non‐specific central nervous system and systemic toxicity
Lapointe, N., St‐Hilaire, M., Martinoli, M., Blanchet, J., Gould, P., Rouillard, C., & Cicchetti, F. (2004) · The FASEB Journal · doi:10.1096/fj.03-0677fje · Cited by 187
Self-citationSystemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats
Cicchetti, F., Lapointe, N., Roberge-Tremblay, A., Saint-Pierre, M., Jimenez, L., Ficke, B. W., & Gross, R. E. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.03.018 · Cited by 187
Self-citationInhibitory effects of pesticides on proteasome activity: Implication in Parkinson's disease
Wang, X.-F., Li, S., Chou, A. P., & Bronstein, J. M. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.012 · Cited by 158
Ossowska, K., Wardas, J., Śmiałowska, M., Kuter, K. Z., Lenda, T., Wierońska, J. M., Zieba, B. A., Nowak, P. G., Dąbrowska, J., Bortel, A. B., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04301.x · Cited by 149
Shimizu, K., Matsubara, K., Ohtaki, K., Fujimaru, S., Saito, O., & Shiono, H. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02750-1 · Cited by 142
Saravanan, K. S., Madathil, S. K., & Mohanakumar, K. P. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.051 · Cited by 135
Role of nitric oxide in rotenone‐induced nigro‐striatal injury
He, Y., Imam, S. Z., Dong, Z., Jankovic, J. J., Ali, S. F., Appel, S. H., & Le, W. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01938.x · Cited by 133
Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally
Ling, Z., Chang, Q. A., Tong, C. W., Leurgans, S. E., Lipton, J. W., & Carvey, P. M. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.08.006 · Cited by 132
Paraquat Neurotoxicity Is Mediated by a Bak-dependent Mechanism
Fei, Q., McCormack, A. L., Monte, D. A. D., & Ethell, D. W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708451200 · Cited by 124
Variable effects of chronic subcutaneous administration of rotenone on striatal histology
Zhu, C., Vourc’h, P., Fernagut, P., Fleming, S. M., Laćan, S., DiCarlo, C. D., Seaman, R. L., & Chesselet, M. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20305 · Cited by 103
Saravanan, K. S., Madathil, S. K., Karuppagounder, S. S., & Mohanakumar, K. P. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.016 · Cited by 92
Paraquat: The Red Herring of Parkinson's Disease Research
Miller, G. W. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm223 · Cited by 87
Richter, F., Hamann, M., & Richter, A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21159 · Cited by 86
Li, X., Matsumoto, K., Murakami, Y., et al. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.09.004 · Cited by 86
Rojo, A. I., Cavada, C., de Sagarra, M. R., & Cuadrado, A. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.022 · Cited by 83
Alam, M., Mayerhofer, A., & Schmidt, W. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.08.014 · Cited by 82
Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats
Kuter, K. Z., Śmiałowska, M., Wierońska, J. M., Zieba, B. A., Wardas, J., Pietraszek, M., Nowak, P. G., Biedka, I., Roczniak, W., Konieczny, J., et al. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.018 · Cited by 80
Sindhu, K. M., Saravanan, K. S., & Mohanakumar, K. P. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.051 · Cited by 78
Barlow, B. K., Thiruchelvam, M. J., Bennice, L., Cory‐Slechta, D. A., Ballatori, N., & Richfield, E. K. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01773.x · Cited by 73
Olfactory pathogenesis of idiopathic Parkinson disease revisited
Lerner, A., & Bagic, A. I. (2008) · Movement Disorders · doi:10.1002/mds.22066 · Cited by 72
Temporal effects of paraquat/maneb on microglial activation and dopamine neuronal loss in older rats
Saint‐Pierre, M., Tremblay, M., Attila Gabor, S. I. K., Gross, R. E., & Cicchetti, F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03923.x · Cited by 62
Self-citationManeb potentiates paraquat neurotoxicity by inducing key Bcl‐2 family members
Fei, Q., & Ethell, D. W. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05293.x · Cited by 61
The Rotenone model of Parkinsonism — the five years inspection
Höglinger, G. U., Oertel, W. H., & Hirsch, É. C. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_41 · Cited by 57
Enhanced sensitivity of dopaminergic neurons to rotenone-induced toxicity with aging
Phinney, A. L., Andringa, G., Bol, J. G. J. M., Wolters, E. C., Muiswinkel, F. L. V., van Dam, A., & Drukarch, B. (2006) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.12.002 · Cited by 57
Madathil, S. K., Banerjee, R., Karuppagounder, S. S., Saravanan, K. S., Raju, B. C., Rao, J. M., & Mohanakumar, K. P. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.05.017 · Cited by 57
Antkiewicz‐Michaluk, L., Wardas, J., Michaluk, J., Romańska, I., Bojarski, A. J., & Vetulani, J. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703004036 · Cited by 55
Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL/6 mice.
Li, X., Yin, J., Cheng, C.-M., Sun, J.-L., Li, Z., & Wu, Y. (2005) · PubMed · Cited by 53
Corasaniti, M. T., DeFilippo, R. E., Rodinò, P., Nappi, G., & Nisticò, G. (1991) · PubMed · Cited by 47
Sleep disturbances in the rotenone animal model of Parkinson disease
García‐García, F., Ponce, S., Brown, R. A., Cussen, V. A., & Krueger, J. M. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.036 · Cited by 45
Yang, Y., Liu, X., Long, Y., Wang, F., Ding, J., Liu, S., Sun, Y., Yao, H., Wang, H., Wu, J., et al. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20467 · Cited by 45
Shepherd, K. R., Lee, E.-S., Schmued, L. C., Jiao, Y., Ali, S. F., Oriaku, E. T., Lamango, N. S., Soliman, K. F. A., & Charlton, C. G. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.02.013 · Cited by 38
Yang, Y., Liu, X., Long, Y., Wang, F., Ding, J.-H., Liu, S.-Y., Sun, Y., Yao, H.-H., Wang, H., Wu, J., et al. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005547 · Cited by 38
Increased sensitivity of striatal dopamine release to H2O2 upon chronic rotenone treatment
Milusheva, E., Baranyi, M., Kittel, Á., Sperlágh, B., & Vizi, E. S. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.02.034 · Cited by 36
A delivery strategy for rotenone microspheres in an animal model of Parkinson's disease
Huang, J., Liu, H., Gu, W., Yan, Z., Xu, Z., Yang, Y., Zhu, X., & Li, Y. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.07.005 · Cited by 36
Influence of paraquat on dopaminergic transporter in the rat brain.
Ossowska, K., Wardas, J., Kuter, K. Z., Nowak, P. G., Dąbrowska, J., Bortel, A. B., Labus, Ł., Kwieciński, A., Krygowska‐Wajs, A., & Wolfarth, S. (2005) · PubMed · Cited by 32
α-synuclein and tyrosine hydroxylase expression in acute rotenone toxicity
Luo, C., Rajput, A. H., Akhtar, S., & Rajput, A. H. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.3.517 · Cited by 15
Cited by
Pathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472
The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
Xicoy, H., Wieringa, B., & Martens, G. J. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0149-0 · Cited by 1,036
Biological Activities of Essential Oils: From Plant Chemoecology to Traditional Healing Systems
Sharifi-Rad, J., Sureda, A., Tenore, G., Daglia, M., Sharifi-Rad, M., Valussi, M., Tundis, R., Sharifi-Rad, M., Loizzo, M., Ademiluyi, A., et al. (2017) · Molecules · doi:10.3390/molecules22010070 · Cited by 889
Duty, S., & Jenner, P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01426.x · Cited by 753
Mitochondrial fusion, fission, and mitochondrial toxicity
Meyer, J. N., Leuthner, T. C., & Luz, A. L. (2017) · Toxicology · doi:10.1016/j.tox.2017.07.019 · Cited by 522
Metadata
- Authors
- Cicchetti, F., Drouin-Ouellet, J., & Gross, R. E.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 30
- Issue
- 9
- Pages
- 475-483
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2074472723
- Cited by
- 311
- References
- 62
- FWCI
- 14.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.